Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Imagotan
2. Psychoson
3. Inofal
4. 14759-06-9
5. Thioridazine 2-sulfone
6. Thioridazine-2-sulfone
7. Tpn-12
8. Thioridazine Sulfone
9. Thioridazine Sulphone
10. 10-(2-(1-methyl-2-piperidyl)ethyl)-2-methylsulfonylphenothiazine
11. 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfonylphenothiazine
12. 10h-phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfonyl)-
13. B7599i244x
14. Phenothiazine, 10-(2-(1-methyl-2-piperidyl)ethyl)-2-methylsulfonyl-
15. Solforidazina [dcit]
16. Solforidazina
17. Sulforidazina
18. Sulforidazinum
19. Tpn 12
20. Sulforidazine [inn:dcf]
21. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfonyl)-
22. Sulforidazinum [inn-latin]
23. Sulforidazina [inn-spanish]
24. Einecs 238-818-7
25. Brn 1230366
26. 2-methylsulfonyl-10-[2-(1-methyl-2-piperidyl)ethyl]phenothiazine
27. (+/-)-thioridazine-2-sulfone
28. 2-methylsulfonyl-10-(2-(1-methyl-2-piperidyl)ethyl)phenothiazine
29. Unii-b7599i244x
30. 2-methylsulfonyl-10-(2-(1-methyl-2-piperidyl)ethyl)phenothiazin
31. Sulforidazine [mi]
32. Sulforidazine [inn]
33. Schembl145025
34. Sulforidazine [mart.]
35. Sulforidazine [who-dd]
36. Chembl2107268
37. Bdbm86723
38. Dtxsid30864531
39. Chebi:135644
40. Nsc_31765
41. Akos030239787
42. Cas_14759-06-9
43. Ft-0675190
44. Thioridazine Impurity E [ep Impurity]
45. L000789
46. J-008369
47. Q7636215
48. Thioridazine Hydrochloride Impurity E [ep Impurity]
49. 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-methylsulfonylphenothiazine
50. 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfonyl)-10h-phenothiazine
51. 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfonyl)-10h-phenothiazine #
52. 2-methanesulfonyl-10-[2-(1-methylpiperidin-2-yl)ethyl]-10h-phenothiazine
53. Phenothiazine, 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfonyl)-
Molecular Weight | 402.6 g/mol |
---|---|
Molecular Formula | C21H26N2O2S2 |
XLogP3 | 4.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 402.14357042 g/mol |
Monoisotopic Mass | 402.14357042 g/mol |
Topological Polar Surface Area | 74.3 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 606 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
ABOUT THIS PAGE
A Sulforidazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulforidazine, including repackagers and relabelers. The FDA regulates Sulforidazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulforidazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulforidazine supplier is an individual or a company that provides Sulforidazine active pharmaceutical ingredient (API) or Sulforidazine finished formulations upon request. The Sulforidazine suppliers may include Sulforidazine API manufacturers, exporters, distributors and traders.
Sulforidazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulforidazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulforidazine GMP manufacturer or Sulforidazine GMP API supplier for your needs.
A Sulforidazine CoA (Certificate of Analysis) is a formal document that attests to Sulforidazine's compliance with Sulforidazine specifications and serves as a tool for batch-level quality control.
Sulforidazine CoA mostly includes findings from lab analyses of a specific batch. For each Sulforidazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulforidazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulforidazine EP), Sulforidazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulforidazine USP).
LOOKING FOR A SUPPLIER?